Cardiovascular disease is a major cause of morbidity and mortality among hemodialysis (HD) and peritoneal dialysis (PD) patients, and dyslipidemia plays an important role in its pathogenesis.
Small, dense LDL (sd-LDL) particles have been recently highlighted as an emerging cardiovascular risk factor.